Avoro Capital Advisors LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 217 filers reported holding IMMUNOMEDICS INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$2,232,038,000
+139.9%
26,250,0000.0%31.71%
+72.4%
Q2 2020$930,300,000
+181.7%
26,250,000
+7.1%
18.39%
+65.0%
Q1 2020$330,260,000
-36.3%
24,500,0000.0%11.15%
-26.8%
Q4 2019$518,420,000
+86.2%
24,500,000
+16.7%
15.22%
+31.0%
Q3 2019$278,460,000
-4.4%
21,000,0000.0%11.62%
+15.4%
Q2 2019$291,270,000
-14.4%
21,000,000
+18.5%
10.07%
-31.6%
Q1 2019$340,295,000
+34.6%
17,714,4610.0%14.72%
-2.6%
Q4 2018$252,785,000
-31.5%
17,714,4610.0%15.11%
-10.8%
Q3 2018$368,992,000
-12.0%
17,714,4610.0%16.94%
+5.0%
Q2 2018$419,301,000
+69.4%
17,714,461
+4.6%
16.14%
+36.6%
Q1 2018$247,486,000
-7.6%
16,939,4610.0%11.82%
-31.9%
Q4 2017$267,827,000
+26.1%
16,939,461
+8.5%
17.36%
+5.4%
Q3 2017$212,358,000
+129.3%
15,614,461
+48.9%
16.47%
+40.9%
Q2 2017$92,610,000
+36.5%
10,488,0760.0%11.69%
+34.9%
Q1 2017$67,858,000
+99.5%
10,488,076
+9.7%
8.67%
+26.1%
Q4 2016$34,019,000
+42.2%
9,564,140
+25.1%
6.87%
+63.8%
Q3 2016$23,922,000
+20.1%
7,644,977
-15.2%
4.20%
-5.2%
Q2 2016$19,916,000
+658.4%
9,010,857
+757.8%
4.42%
+383.1%
Q1 2016$2,626,0001,050,4570.92%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders